A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood
NCT07781631 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-08-24
Summary
The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.
Conditions
- Healthy
Interventions
- DRUG
-
Verducatib
Verducatib
- DRUG
-
Carbamazepine
Carbamazepine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-10
- Primary Completion
- 2026-12-14
- Completion
- 2026-12-20
Countries
- Germany
Study Locations
More Related Trials
-
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
NCT06745297 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL
NCT01587417 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706
NCT01763333 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers
NCT02093819 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
NCT06716190 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male Volunteers
NCT01681277 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)
NCT02254148 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
NCT01611311 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers
NCT02106247 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Tolerability and Pharmacokinetic of BI 411034
NCT01581684 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
NCT03971695 ·Status: COMPLETED ·Phase: PHASE1
-
Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects
NCT02211885 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women
NCT06916702 ·Status: SUSPENDED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX
NCT01587391 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study of BI 690517 in Healthy Volunteers
NCT02891148 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults
NCT06984926 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
NCT06631430 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety and Efficacy of Multiple Doses of VB-201 on Biomarkers
NCT01159730 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Rising Dose of BI 1181181 Given Orally in Young Healthy Male and Elderly Healthy Male/Female Volunteers
NCT02254161 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects
NCT02211157 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects
NCT05087069 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood
NCT07774325 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation
NCT01478529 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers
NCT02214940 ·Status: COMPLETED ·Phase: PHASE1